A double-blind, placebo-controlled study of tacrine in Chinese patients with Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue 4, 1999, Pages 289-294

  Wong, Wen Jang ^a   Liu, Hsiu Chih ^a   Fuh, Jong Ling ^a   Wang, Shuu Jiun ^a   Hsu, Li Chi ^a   Wang, Pei Ning ^a   Sheng, Wen Yung ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acetylcholinesterase inhibitor; Alzheimer's disease; Dementia; Tacrine

Indexed keywords

ALANINE AMINOTRANSFERASE; NOOTROPIC AGENT; TACRINE;

ADULT; AGED; ALZHEIMER DISEASE; ANOREXIA; ARTICLE; CHINESE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VOMITING;

AGED; ALANINE TRANSAMINASE; ALZHEIMER DISEASE; ANOREXIA; ASIAN CONTINENTAL ANCESTRY GROUP; DOUBLE-BLIND METHOD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; PSYCHIATRIC STATUS RATING SCALES; TACRINE; TAIWAN; TREATMENT OUTCOME;

EID: 0033004695     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017134     Document Type: Article

References (22)

1. Katzman R: Alzheimer's disease. N Engl J Med 1986;314:964-973.
2. Liu CK, Lin RT, Chen YF, Tai CT, Yen YY, Howng SL: Prevalence of dementia in an urban area in Taiwan. J Formos Med Asssoc 1996;95: 762-768.
3. Liu HC, Lin KN, Teng EL, Wang SJ, Fuh JL et al: Prevalence and subtypes of dementia in Taiwan: A community survey of 5297 individuals. J Am Geriatr Soc 1995;43:144-149.
4. Yip PK, Shyu TI, Lee JY, et al: Prevalence of dementia in the elderly in an urban district of Taipei. Acta Neurol Sin 1992;1:347-354.
5. Davies P, Moloney AJF: Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;ii:1043.
6. Dartus RT, Dean RT III, Deer B, Lippa AS: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-417.
7. Davis KL, Mohs RC: Enhancement of memory processes in Alzheimer's disease with multiple dose intravenous physostigmine. Am J Psychiatry 1982;139:1421-1424.
8. Mohs RC, Davis BM, Johns CA, et al: Oral physostigmine treatment of patients with Alzheimer's disease. Am J Psychiatry 1985;142: 28-33.
9. Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A: Oral tetrahydro-aminoacridine in long-term treatment of senile dementia, Alzheimer's type. N Engl J Med 1988;315: 1241-1245.
10. Eagger SA, Levy R, Sahakian BJ: Tacrine in Alzheimer's disease. Lancet 1991;337:989-992.
11. Davis KL, Thai LJ, Gamzu ER, et al and the Tacrine Collaborative Study Group: A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992;327:1253-1259.
12. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J, for the Tacrine Study Group: A controlled trial of tacrine in Alzheimer's disease. JAMA 1992;268:2523-2529.
13. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS. Gracon SI, for the Tacrine Study Group: A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994;13:985-991.
14. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW: Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994;271:992-998.
15. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Reports of the NINCDS-ARDRA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
16. Holstein MF, Folstein SE, McHugh PR: 'Minimental state' a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, et al: The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45-56.
18. Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989;19:1015-1022.
19. Liu HC, Chou P, Lin KN, Wang SJ, Fuh JL, et al: Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol Med 1994; 24:763-767.
20. Summers WK, DeBoynton V, Marsh GM, Majovski LV: Comparison of seven psychometric instruments used for evaluation of treatment effect in Alzheimer's dementia. Neuroepidemiology 1990;9:193-207.
21. Salmon DP, Thai LJ, Butters N, Heindel WC: Longitudinal evaluation of dementia of the Alzheimer type: A comparison of 3 standardized mental status examination. Neurology 1990;40:1225-1230.
22. Becker JT, Huff FJ, Nebes RD, Holland A, Boiler F: Neuropsychological function in Alzheimer' disease: Pattern of impairment and rate of progression. Arch Neurol 1988;45:263-268.